Prelude Therapeutics (PRLD)'s 30-day implied volatility (IV30) was 88.1% at the close on October 19, 2026, down from 93.5% the day before, against a 52-week range of 81.5% to 268.5%. Its 20-day historical volatility was 76.4%.
Data as of October 19, 2026.